ArticleClinical pharmacology and therapeutics2025
Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.
Florian Lemaitre et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.